Search Within

Erika Gedvilaite

Formats
  1. Meeting Abstract (27)
  2. Journal Article (12)
  3. Editorial (1)
  4. Research Letter (1)
Groups
  1. Department of Pathology and Laboratory Medicine (35)
  2. GSK Faculty (34)
  3. Human Oncology and Pathogenesis Program (33)
  4. Department of Medicine (28)
  5. Center for Molecular Imaging and Biotechnology (CMIB) (26)
  6. Solid Tumor Oncology Division (24)

More Groups

People
  1. Ryan Ptashkin (18)
  2. Marc Ladanyi (17)
  3. Wai Yi Tsui (17)
  4. Michael Berger (16)
  5. Ahmet Zehir (12)
  6. Angela Brannon (12)

More People

Years
  1. 2025 (3)
  2. 2024 (4)
  3. 2023 (9)
  4. 2022 (6)
  5. 2021 (5)
  6. 2020 (5)

More Years

Publications
  1. Clinical Cancer Research (5)
  2. Journal of Clinical Oncology (5)
  3. Journal of Molecular Diagnostics (4)
  4. Blood (3)
  5. Cancer Research (3)
  6. JCO Precision Oncology (2)

More Publications

Publishers
  1. American Association for Cancer Research (8)
  2. American Society of Clinical Oncology (7)
  3. Elsevier Science, Inc. (4)
  4. Nature Publishing Group (4)
  5. American Society of Hematology (3)
  6. Oxford University Press (3)

More Publishers

Results (41)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Allele-specific loss or mutations in CDKN2A/B worsen overall survival in IDH-mutant astrocytomas
    Meeting Abstract

    Hickman, R.; Gedvilaite, E.; Ptashkin, R.; Cimera, R.; Vanderbilt, C.; Benhamida, J.; Fahy, T.; Young, R.; Miller, A.; Mellinghoff, I.; more...
    Journal of Neuropathology and Experimental Neurology (2023)

    Fulltext@MSK | Save
  • IDH-mutant astrocytomas with primitive neuronal component are aggressive tumors characterized by alterations in RB1 and TP53
    Meeting Abstract

    Slocum, C.; Hickman, R.; Gedvilaite, E.; Ptashkin, R.; Brannon, R.; Ladanyi, M.; Miller, A.; Pentsova, E.; Tabar, V.; Young, R.; more...
    Journal of Neuropathology and Experimental Neurology (2023)

    Fulltext@MSK | Save
  • Allele-specific CDKN2A/B loss worsens overall survival in IDH-mutant astrocytomas
    Meeting Abstract

    Hickman, R. A.; Gedvilaite, E.; Ptashkin, R.; Cimera, R.; Vanderbilt, C.; Benhamida, J.; Fahy, T.; Young, R.; Miller, A.; Mellinghoff, I.; more...
    Journal of Molecular Diagnostics (2023)

    Fulltext@MSK | Save
  • Validation of an ultra-sensitive genomic NGS assay for hematological malignancies
    Meeting Abstract

    DiNapoli, S. E.; Gedvilaite, E.; Bowman, A.; Xu, F.; Parikh, A. D.; Diosdado, M.; Cassanova-Murphy, J.; Rana, S.; Haque, M. H.; Hale, C.; more...
    Journal of Molecular Diagnostics (2023)

    Fulltext@MSK | Save
  • Microsatellite instability defines a subset of lung cancers with smoking exposure, high tumor mutational burden and MLH1 inactivation
    Meeting Abstract

    Yang, S. R.; Gedvilaite, E.; Ptashkin, R.; Chang, J.; Ziegler, J.; Mata, D.; Villafania, L. B.; Nafa, K.; Hechtman, J. F.; Benhamida, J.; more...
    Journal of Thoracic Oncology (2023)

    Fulltext@MSK | Save
  • Predicting tumour content of liquid biopsies from cell-free DNA
    Journal Article

    Cardner, M.; Marass, F.; Gedvilaite, E.; Yang, J. L.; Tsui, D. W. Y.; Beerenwinkel, N.
    BMC Bioinformatics (2023)

    Fulltext@MSK | Save
  • Matched molecular profiling of cell-free DNA and tumor tissue in patients with advanced clear cell renal cell carcinoma
    Journal Article

    Kotecha, R. R.; Gedvilaite, E.; Ptashkin, R.; Knezevic, A.; Murray, S.; Johnson, I.; Shapnik, N.; Feldman, D. R.; Carlo, M. I.; Shah, N. J.; more...
    JCO Precision Oncology (2022)

    Fulltext@MSK | Save
  • MSK-ACCESS Heme: A cell-free DNA next-generation sequencing assay to identify somatic alterations in patients with lymphoma
    Meeting Abstract

    DiNapoli, S. E.; Spence, C.; Gedvilaite, E.; Bowman, A.; Diosdado, M.; Razumova, A.; Tsui, D.; Salles, G. A.; Batlevi, C.; von Keudell, G.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Validation of a cell-free DNA NGS assay for hematological malignancies
    Meeting Abstract

    Gedvilaite, E.; DiNapoli, S.; Spence, C.; Diosdado, M. S.; Razumova, A.; Bowman, A. S.; Tsui, D. W. Y.; Salles, G.; Batlevi, C. L.; von Keudell, G.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • Rb tumor suppressor in small cell lung cancer: Combined genomic and IHC analysis with a description of a distinct Rb-proficient subset
    Editorial

    Febres-Aldana, C. A.; Chang, J. C.; Ptashkin, R.; Wang, Y.; Gedvilaite, E.; Baine, M. K.; Travis, W. D.; Ventura, K.; Bodd, F.; Yu, H. A.; more...
    Clinical Cancer Research (2022)

    Fulltext@MSK | Save